NCT00734487View on ClinicalTrials.gov

AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study

CompletedOBSERVATIONAL
Enrollment

470

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Age Related Macular Degeneration
Trial Locations (4)

20892

National Eye Institute, Bethesda

27705

Duke University Eye Center, Durham

30322

Emory University Eye Center, Atlanta

97210

Devers Eye Center, Portland

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Duke University

OTHER

NCT00734487 - AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study | Biotech Hunter | Biotech Hunter